Effectiveness and safety of direct oral anticoagulants in patients with non-valvular atrial fibrillation and liver disease
Effectiveness and safety of direct oral anticoagulants in patients with non-valvular atrial fibrillation and liver disease
直接口服抗凝药对非瓣膜性心房颤动和肝病患者的有效性和安全性
批准号：
402019
负责人：
Douros Antonios
金额：
$16.44万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-03-01 至 2022-03-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Atrial fibrillation (AF) is a common heart arrythmia that increases the risk of stroke. Direct oral anticoagulants (DOACs) are blood thinners used to prevent stroke in patients with this heart arrhythmia. However, DOACs may also increase the risk of bleed
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Concomitant use of sulfonylureas with warfarin and the risk of severe hypoglycemia in patients with type 2 diabetes
-
批准号：403240
-
项目类别：Operating Grants
-
资助金额：$10.87万
-
财政年份：2019
-
负责人：Douros Antonios
-
依托单位：
海外基金
